Sight Sciences Inc. is a company specializing in medical technology aimed at addressing eye diseases. The primary function of the company is to develop and commercialize innovative ophthalmic products, particularly for conditions such as glaucoma and dry eye syndrome. Their notable technologies include the OMNI Surgical System, which is designed to address the full range of outflow pathways involved in glaucoma treatment, and the TearCare System for more efficient treatment of evaporative dry eye. Sight Sciences Inc. plays a vital role in the healthcare sector, particularly in the field of ophthalmology, and is driven by a mission to transform eye care through highly effective and minimally invasive solutions. By focusing on underserved patient populations, the company not only impacts individual patient outcomes but also contributes to advancing the standards of eye disease management globally. With its headquarters in the United States, Sight Sciences is part of the broader medical technology community that continues to innovate in pursuit of better health outcomes.